Annual Drug Patent Expirations for VIZAMYL
Vizamyl is a drug marketed by Ge Healthcare and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has seventy-two patent family members in twenty-five countries.
The generic ingredient in VIZAMYL is flutemetamol f-18. One supplier is listed for this compound. Additional details are available on the flutemetamol f-18 profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
